← Back

Park Ha Biological Technology Co., Ltd.

Park Ha Biological Technology Co., Ltd. is an investment holding company that develops skincare products in the People's Republic of China. It operates through two segments: Product Sales and Franchise Service. Under the Park Ha brand, it offers products ranging from basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, as well as anti-aging products, sold through directly operated retail stores and franchisees. The company has a strategic partnership with Star Plus Action (HK) Limited to build an AI-powered skincare and health ecosystem and expand its healthcare reach, and another with Cloud Factory Technology Holdings Limited to build an AI-driven ecosystem for the beauty industry. Founded in 2016 and headquartered in Wuxi, the People's Republic of China, it operates as a subsidiary of Xiaoqiu Holding Ltd.

Country
Price · split & dividend adjusted
News & notes moving BYAH
BYAH

Robbins LLP Reminds Park Ha Biological Technology Investors of September 28 Lead Plaintiff Deadline

Robbins LLP reminds investors that a securities class action has been filed against Park Ha Biological Technology Co., Ltd. on behalf of purchasers of its securities between December 27, 2024 and July 8, 2025. The lawsuit alleges Park Ha was the subject of a market manipulation and fraudulent promotion scheme involving social-media misinformation and impersonated financial professionals, and that the company failed to adequately disclose associated risks. According to the complaint, Park Ha's stock price surged from its $4.00 IPO price to an all-time high of $41.49 on July 7, 2025, before collapsing 93% in a single day on July 8, 2025, wiping out more than $1 billion in market capitalization. Investors who suffered losses during the class period may seek appointment as lead plaintiff by the September 28, 2026 deadline.
GlobeNewswire·49dRead more →
BYAH3

Bronstein, Gewirtz & Grossman Files Class Action Against Park Ha Biological Technology

Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Park Ha Biological Technology Co., Ltd. and certain officers, alleging violations of federal securities laws. The suit covers investors who purchased Park Ha securities between December 27, 2024 and July 8, 2025. The complaint claims the company failed to disclose a fraudulent stock promotion and market manipulation scheme involving social media misinformation and impersonation of financial professionals, and that its IPO was structured with an extremely low public float to facilitate the manipulation. Investors have until September 21, 2026 to seek lead plaintiff appointment. The firm represents investors on a contingency fee basis.
GlobeNewswire·50dRead more →
BYAH2

Park Ha Biological Technology Co., Ltd. Announces Official Approval of Its North American Amazon Store

Park Ha Biological Technology Co., Ltd. has officially received approval to open a store on Amazon North America, marking a critical milestone in its global expansion strategy. The company completed all registration procedures after passing Amazon's rigorous evaluation of brand qualifications, operational compliance, and market reputation. This launch transitions Park Ha Biological from a premium domestic brand to an emerging international brand, unlocking access to the global high-end consumer market. The company plans to leverage Amazon's global traffic, Fulfillment by Amazon logistics, brand tools, and data resources to tailor products for North American consumers and enhance cross-border brand operations.
GlobeNewswire·74dRead more →
BYAH

Park Ha Biological Technology applies for PCPC membership to support Amazon North America entry

Park Ha Biological Technology has formally submitted a complete membership application to the Personal Care Products Council, marking a strategic step in its expansion into Amazon's North America marketplace. The application includes all required corporate qualifications, raw material compliance documentation, and product safety materials, which are now under review. Founded in 1894, PCPC represents over 90% of major U.S. cosmetics and skincare companies and is the primary architect of key regulatory frameworks such as MoCRA and FDA cosmetic standards. The company stated that joining PCPC is a cornerstone of its long-term globalization strategy, aiming to build a resilient overseas supply chain through the council's global membership network. The membership application has been advanced in parallel with the company's cooperation with Amazon North America.
GlobeNewswire·79dRead more →